International Isotopes, Inc.

International Isotopes, Inc. is a U.S.-based company founded in 1995 and headquartered in Idaho Falls, Idaho. The company specializes in the manufacture and distribution of radioactive source products for nuclear medicine, molecular imaging, cancer therapy, and calibration standards. The company operates through several segments, including Theranostics Products, which involves the production of isotopically pure radiopharmaceuticals and active pharmaceutical ingredients. They manufacture generic Sodium Iodide I-131, an FDA-approved treatment for hyperthyroidism and thyroid cancer. Their Cobalt Products segment focuses on Cobalt-60 sealed sources for cancer treatment and security scanning. Additionally, they produce calibration standards for nuclear pharmacies and SPECT/PET imaging systems. International Isotopes also offers contract manufacturing services and supplies radioisotope APIs for third-party clients. They distribute and service advanced radiosynthesis modules and have a joint venture with Alpha Nuclides to expand their reach into China. The company serves a diverse customer base, including nuclear pharmacies, hospitals, and government agencies.

• Employees 41
• Founded 1995
• Annual Revenue $14234000
• Total Funding $3930050